Dr. Greg Clary, MD

NPI: 1659317360
Total Payments
$1,203
2024 Payments
$17.79
Companies
13
Transactions
90
Medicare Patients
374
Medicare Billing
$32,595

Payment Breakdown by Category

Food & Beverage$1,173 (97.5%)
Education$29.99 (2.5%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,173 89 97.5%
Education $29.99 1 2.5%

Top Paying Companies

Company Total Records Latest Year
Allergan Inc. $263.15 27 $0 (2019)
Sunovion Pharmaceuticals Inc. $255.28 14 $0 (2020)
Neurocrine Biosciences, Inc. $141.37 2 $0 (2021)
Merck Sharp & Dohme Corporation $139.18 13 $0 (2017)
Alkermes, Inc. $112.78 12 $0 (2017)
Janssen Pharmaceuticals, Inc $88.77 6 $0 (2019)
Shire North American Group Inc $46.29 4 $0 (2017)
Otsuka America Pharmaceutical, Inc. $45.92 3 $0 (2017)
Lundbeck LLC $28.07 2 $0 (2017)
Takeda Pharmaceuticals America, Inc. $26.68 3 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $17.79 1 SHIELD THERAPEUTICS INC ($17.79)
2021 $141.37 2 Neurocrine Biosciences, Inc. ($141.37)
2020 $13.65 1 Sunovion Pharmaceuticals Inc. ($13.65)
2019 $55.93 4 Janssen Pharmaceuticals, Inc ($29.61)
2018 $169.24 17 Allergan Inc. ($138.42)
2017 $804.58 65 Sunovion Pharmaceuticals Inc. ($210.81)

All Payment Transactions

90 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/20/2024 SHIELD THERAPEUTICS INC ACCRUFER (Drug) Food and Beverage In-kind items and services $17.79 General
Category: Hematology
06/10/2021 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $16.37 General
Category: NEUROLOGY
04/29/2021 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: NEUROLOGY
01/24/2020 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $13.65 General
Category: CNS
12/10/2019 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $14.67 General
Category: Neuroscience
12/04/2019 Neuronetics, Inc. NEUROSTAR TMS THERAPY (Device) Food and Beverage In-kind items and services $13.63 General
Category: NEUROSTAR TMS THERAPY
10/24/2019 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $12.69 General
Category: NEUROSCIENCE
05/30/2019 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $14.94 General
Category: Neuroscience
10/29/2018 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $12.15 General
Category: NEUROSCIENCE
10/18/2018 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $1.00 General
Category: NEUROSCIENCE
10/04/2018 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $0.86 General
Category: NEUROSCIENCE
08/17/2018 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $12.77 General
Category: NEUROSCIENCE
08/10/2018 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $16.26 General
Category: CNS
08/03/2018 Allergan Inc. VIIBRYD (Drug) Food and Beverage In-kind items and services $0.89 General
Category: NEUROSCIENCE
07/19/2018 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $12.77 General
Category: NEUROSCIENCE
07/13/2018 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $0.89 General
Category: NEUROSCIENCE
06/29/2018 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.26 General
Category: NEUROSCIENCE
06/01/2018 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $0.92 General
Category: NEUROSCIENCE
05/17/2018 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.78 General
Category: NEUROSCIENCE
05/10/2018 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $0.83 General
Category: NEUROSCIENCE
04/10/2018 Allergan Inc. VRAYLAR (Drug) Education In-kind items and services $29.99 General
Category: NEUROSCIENCE
03/16/2018 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.34 General
Category: NEUROSCIENCE
02/16/2018 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $10.63 General
Category: NEUROSCIENCE
02/09/2018 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $14.56 General
Category: CNS
01/31/2018 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.34 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 1 20 55 $9,618 $2,815
2021 5 142 264 $49,185 $14,376
2020 7 212 295 $47,673 $15,404
Total Patients
374
Total Services
614
Medicare Billing
$32,595
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 20 55 $9,618 $2,815 29.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 55 162 $29,160 $8,477 29.1%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 26 26 $8,710 $2,535 29.1%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2021 31 43 $4,300 $1,204 28.0%
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2021 12 14 $3,500 $1,097 31.4%
99238 Hospital discharge day management, 30 minutes or less Facility 2021 18 19 $3,515 $1,062 30.2%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 42 83 $14,940 $4,735 31.7%
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2020 34 34 $8,500 $2,570 30.2%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2020 44 70 $7,000 $2,136 30.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 21 30 $4,644 $1,928 41.5%
99238 Hospital discharge day management, 30 minutes or less Facility 2020 25 25 $4,625 $1,421 30.7%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 33 40 $3,608 $1,319 36.6%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 13 13 $4,355 $1,295 29.7%

About Dr. Greg Clary, MD

Dr. Greg Clary, MD is a Psychiatry healthcare provider based in High Point, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659317360.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Greg Clary, MD has received a total of $1,203 in payments from pharmaceutical and medical device companies, with $17.79 received in 2024. These payments were reported across 90 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,173).

As a Medicare-enrolled provider, Clary has provided services to 374 Medicare beneficiaries, totaling 614 services with total Medicare billing of $32,595. Data is available for 3 years (2020–2022), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Other Specialties Psychiatry, Internal Medicine
  • Location High Point, NC
  • Active Since 06/21/2006
  • Last Updated 10/14/2025
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1659317360

Products in Payments

  • VRAYLAR (Drug) $261.40
  • LATUDA (Drug) $255.28
  • INGREZZA (Drug) $141.37
  • BELSOMRA (Drug) $139.18
  • Aristada 441 mg (Drug) $112.78
  • REXULTI (Drug) $49.43
  • INVEGA TRINZA (Drug) $40.47
  • VYVANSE (Drug) $35.21
  • INVEGA SUSTENNA (Drug) $33.63
  • Trintellix (Drug) $26.68
  • ACCRUFER (Drug) $17.79
  • SPRAVATO (Drug) $14.67
  • TRINTELLIX (Drug) $14.07
  • NEUROSTAR TMS THERAPY (Device) $13.63
  • SUBOXONE SUBLINGUAL FILM (Drug) $12.01
  • NeuroStar TMS Therapy (Device) $11.64
  • MYDAYIS (Drug) $11.08
  • ABILIFY MAINTENA (Drug) $10.49
  • VIIBRYD (Drug) $1.75

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in High Point